IART
Price
$21.73
Change
-$0.06 (-0.28%)
Updated
Dec 23, 10:52 AM (EDT)
58 days until earnings call
RVP
Price
$0.62
Change
-$0.02 (-3.12%)
Updated
Dec 23, 02:43 PM (EDT)
Ad is loading...

IART vs RVP

Header iconIART vs RVP Comparison
Open Charts IART vs RVPBanner chart's image
Integra LifeSciences Holdings
Price$21.73
Change-$0.06 (-0.28%)
Volume$500
CapitalizationN/A
Retractable Technologies
Price$0.62
Change-$0.02 (-3.12%)
Volume$598
CapitalizationN/A
IART vs RVP Comparison Chart
Loading...
IART
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RVP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IART vs. RVP commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IART is a Hold and RVP is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (IART: $21.80 vs. RVP: $0.64)
Brand notoriety: IART and RVP are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: IART: 181% vs. RVP: 121%
Market capitalization -- IART: $2.77B vs. RVP: $35.92M
IART [@Medical Specialties] is valued at $2.77B. RVP’s [@Medical Specialties] market capitalization is $35.92M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IART’s FA Score shows that 1 FA rating(s) are green whileRVP’s FA Score has 1 green FA rating(s).

  • IART’s FA Score: 1 green, 4 red.
  • RVP’s FA Score: 1 green, 4 red.
According to our system of comparison, RVP is a better buy in the long-term than IART.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IART’s TA Score shows that 5 TA indicator(s) are bullish while RVP’s TA Score has 5 bullish TA indicator(s).

  • IART’s TA Score: 5 bullish, 4 bearish.
  • RVP’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, RVP is a better buy in the short-term than IART.

Price Growth

IART (@Medical Specialties) experienced а -9.28% price change this week, while RVP (@Medical Specialties) price change was +0.63% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.55%. For the same industry, the average monthly price growth was +0.21%, and the average quarterly price growth was +2.12%.

Reported Earning Dates

IART is expected to report earnings on Feb 19, 2025.

RVP is expected to report earnings on Nov 18, 2024.

Industries' Descriptions

@Medical Specialties (-0.55% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IART($2.77B) has a higher market cap than RVP($35.9M). IART has higher P/E ratio than RVP: IART (41.30) vs RVP (8.13). RVP YTD gains are higher at: -42.342 vs. IART (-49.943). IART has higher annual earnings (EBITDA): 256M vs. RVP (-3.92M). IART has more cash in the bank: 309M vs. RVP (44.9M). RVP has less debt than IART: RVP (1.61M) vs IART (1.68B). IART has higher revenues than RVP: IART (1.54B) vs RVP (42M).
IARTRVPIART / RVP
Capitalization2.77B35.9M7,724%
EBITDA256M-3.92M-6,532%
Gain YTD-49.943-42.342118%
P/E Ratio41.308.13508%
Revenue1.54B42M3,671%
Total Cash309M44.9M688%
Total Debt1.68B1.61M104,472%
FUNDAMENTALS RATINGS
IART vs RVP: Fundamental Ratings
IART
RVP
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
56
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8994
PRICE GROWTH RATING
1..100
6164
P/E GROWTH RATING
1..100
74
SEASONALITY SCORE
1..100
5042

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RVP's Valuation (56) in the Medical Specialties industry is in the same range as IART (77). This means that RVP’s stock grew similarly to IART’s over the last 12 months.

RVP's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as IART (100). This means that RVP’s stock grew similarly to IART’s over the last 12 months.

IART's SMR Rating (89) in the Medical Specialties industry is in the same range as RVP (94). This means that IART’s stock grew similarly to RVP’s over the last 12 months.

IART's Price Growth Rating (61) in the Medical Specialties industry is in the same range as RVP (64). This means that IART’s stock grew similarly to RVP’s over the last 12 months.

RVP's P/E Growth Rating (4) in the Medical Specialties industry is in the same range as IART (7). This means that RVP’s stock grew similarly to IART’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IARTRVP
RSI
ODDS (%)
Bullish Trend 4 days ago
54%
Bullish Trend 4 days ago
68%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
62%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
74%
Bullish Trend 4 days ago
74%
MACD
ODDS (%)
Bearish Trend 5 days ago
58%
Bullish Trend 4 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
70%
Bullish Trend 4 days ago
73%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
71%
Bullish Trend 4 days ago
76%
Advances
ODDS (%)
Bullish Trend 12 days ago
62%
Bullish Trend 4 days ago
71%
Declines
ODDS (%)
Bearish Trend 5 days ago
73%
Bearish Trend 6 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
64%
Bullish Trend 4 days ago
67%
Aroon
ODDS (%)
Bullish Trend 7 days ago
64%
Bearish Trend 4 days ago
88%
View a ticker or compare two or three
Ad is loading...
IART
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RVP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RCKT11.560.21
+1.85%
Rocket Pharmaceuticals
FROG30.860.30
+0.98%
JFrog Ltd
CMI351.381.68
+0.48%
Cummins
WHF9.93-0.13
-1.24%
WhiteHorse Finance
BIVI1.90-0.18
-8.65%
BioVie Inc

IART and

Correlation & Price change

A.I.dvisor indicates that over the last year, IART has been loosely correlated with MASI. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if IART jumps, then MASI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IART
1D Price
Change %
IART100%
+0.41%
MASI - IART
45%
Loosely correlated
-0.28%
LUNG - IART
39%
Loosely correlated
+3.71%
AORT - IART
36%
Loosely correlated
+1.82%
QDEL - IART
36%
Loosely correlated
+4.21%
DXR - IART
35%
Loosely correlated
+2.58%
More